NEWS MAKER @NEWS_MAKER
The German company is already designing a coronavirus vaccine adapted to the new variant, using Omicron’s spike protein and its 32 mutations as an antigen. Sahin announced this should be ready by March. https://t.co/DHy6yQxKVX — PolitiTweet.org